
Malin invests in and supports highly innovative life sciences companies developing cutting-edge science and technology to deliver transformative outcomes for patients and create significant value for shareholders. Headquartered in Ireland and listed on the Euronext Growth Market of Euronext Dublin, Malin aims to generate substantial returns for shareholders through long-term capital and strategic support to its investee companies. Focused on therapeutic areas like oncology, immunology, and genetic diseases, Malin prioritizes business integrity, collaboration with talented individuals, and the development of groundbreaking therapies where current treatments are inadequate.